| Name | CA-4948 |
|---|---|
| Synonyms | N-(1-(6'-amino-[2,3'-bipyridin]-5-yl)vinyl)-2-morpholinooxazolo[4,5-c]pyridin-6-amine |
| Description | CA-4948 is a selective and potent IRAK4 inhibitor. |
|---|---|
| Related Catalog | |
| Target |
IRAK4[1] |
| In Vivo | CA-4948 is a selective and potent IRAK4 inhibitor which can be used as a therapeutic agent for hematological cancers with dysregulated TLR/MYD88/IRAK4 signaling. CA-4948 exhibits favorable DMPK properties, oral bioavailability, and is well tolerated in mice. Furthermore, CA-4948 is previously shown to exhibit dose-dependent efficacy in ABC-DLBCL MYD88-L265P xenograft tumor models[1]. |
| References |
| Molecular Formula | C21H19N7O3 |
|---|---|
| Molecular Weight | 417.42 |
| Storage condition | -20℃ |